- Cell Culture Basics – Mycoplasma 101 – A practical guide to prevention, detection and elimination of mycoplasma contaminationPosted 3 hours ago
- Going to BPI West 2017? Don’t miss these great talks and activities!Posted 6 days ago
- Cool Tool – PRIME-XV® T Cell CDM – First Commercially Available Chemically-defined, Animal-component-free Medium for T Cell CulturePosted 1 week ago
- Increasing Protein Production with Novel Cell-Ess Titer Boost without Affecting the Metabolic ProfilePosted 2 weeks ago
- Continuous Processing Optimization with Smarter ToolsPosted 2 weeks ago
- Cool Tool – Generation of Neural Stem Cells from AlphaSTEM Cultured Pluripotent Stem CellsPosted 2 weeks ago
- Synergizing Transient and Stable Protein Expression for Accelerated Biotherapeutic DevelopmentPosted 2 weeks ago
- Cell Culture Dish Top Ten Ask the Expert Sessions and Podcasts of 2016Posted 3 weeks ago
- A Look at the Current State of Continuous BioprocessingPosted 3 weeks ago
- Cool Tool – Biomek i-Series – Next Generation Automated Workstations Specifically Designed to Meet Evolving WorkflowsPosted 3 weeks ago
How to Improve Protein Productivity Through Scale Up, Including Single-Use Bioreactors
Enhancing protein production is a common goal in the biomanufacturing industry. However, scalability is a problem faced across many platforms in manufacturing. A desired outcome observed in shake flasks, such as increased protein productivity, is not always observed in large scale bioreactors. Further, the move toward single-use bioreactors has posed an additional challenge, as productivity improvements observed in glass shake flasks or stainless steel bioreactors may not be observed in plastic bioreactor bags. Availability of lipids in media is one factor to consider during bioproduction scale-up and when moving toward single-use system.
This session is sponsored by Essential Pharmaceuticals
During this Ask the Expert session, we will be discussing considerations to be made regarding bioproduction scale-up and single-use bioreactors. Essential Pharmaceuticals is addressing these challenges with their Cell-Ess lipid supplement. Cell-Ess was used as a feed at 5% (v/v) in a small Wave bioreactor resulting in greater than 25% monoclonal antibody titer increase, which was similar to the gains seen in earlier experiments using shake flasks. Small bioreactors have been used as models to show scalability to up to 10,000-liter manufacturing runs. These new data suggest supplementing with Cell-Ess as a feed will result in increased monoclonal antibody titers for 10,000-liter bioreactor runs, including in single-use bioreactors.
Who should visit?
- Those in early development of bioproduction of proteins in eukaryotic cells
- Those in media optimization or yield optimization for scaled bioproduction of proteins
- Department Directors, Program Directors, Project leaders, involved in optimization of large scale bioproduction of proteins.
Types of Questions?
- How does lipid availability in media influence protein productivity?
- What can contribute to differences observed during the scale up process?
- Why might lipid availability be different in single-use bioreactors?
- What mitigations can improve lipid half-life and availability in media?
- How can supplements be used in large scale bioproduction to improve protein productivity?
This Ask the Expert session is sponsored by Essential Pharmaceuticals and is hosted by Dr. Adam Elhofy, Ph.D., CSO. Dr. Elhofy developed the core technology for the Ess line of products and aided in creating patents around novel uses of materials. Dr. Elhofy has over 14 years of scientific research experience in the areas of immunology, neuroscience, and oncology. He was funded by both the National Institutes of Health and the Multiple Sclerosis society as an investigator at Northwestern University Medical School. His doctoral research won him the award of the Top 5 trainee scientists by the American Association of Immunologists. Dr. Elhofy has 14 scientific publications in peer reviewed journals. He has played a variety of roles with start-up biotech companies ranging from Principal Investigator to Director of Corporate Development.
For more information, please see “New Advances Pose New Challenges to Bioproduction.”
Please take advantage of the opportunity to ask our expert a question and participate in a lively discussion on animal origin free media optimization.
Questions & Answers
We are adding simple fatty acids to our media, and we use plastic bioreactors. Are our simple fatty acids sticking to the plastic, or is it just complex fatty acids that are the problem?Free fatty acids are added in some media optimization strategies. Free fatty acids have a very short half-life once they are in solution. Furthermore, all types of free fatty acids (both simple and complex) bind to vessel walls, especially in SUBs, where they will be mostly adhere to the vessel with 24 hours.» Read More
Have you looked at the effect of your product on glycosylation profile or charge variants? We are trying to match an existing product profile.We have looked at glycosylation. We do not significantly change the glycosylation pattern. In fact we have preliminary evidence to suggest Cell-Ess may create an environment for more reproducible glycosylation profiles.» Read More
I am curious, we are getting good productivity in our glass benchtop bioreactors, but when we scale up to 200 liters, our productivity drops. We have seen that this is due to a decrease in vcd. What could you recommend we try?We have seen similar results in glass, steel, and SUBs with Cell-Ess. I have several questions and maybe we can go through them together offline. For example what does your VCD curve look like in each vessel? Do you know what may account for the different curve shapes? There are several other questions we can […]» Read More
We work with CHO transfection pools for protein production. We typically use a more complex media for this application. Have you seen your product can be helpful with transfection pools?We have seen a benefit in CHO cell pools. As with isolated clones used for production, the base SFM drives the amount of Cell-Ess needed for an observed benefit. The typical time for pools grown is shorter than that for production runs so most likely an initial supplement tends to be sufficient. We can work […]» Read More
Can this be used for MDCK cells? We are culturing cells in a WAVE bioreactor, and they could use some help with growth and viability.Cell-Ess has been used with MDCK cells that were adapted from serum. We have not tried Cell-Ess as a supplement to MDCK cells grown in an SFM. We anticipate there would also be a benefit based on the results of the serum adapted CHO cells.» Read More
We are using HEK cells for our smaller scale protein production. Have you tried this supplement in HEK?We are currently trying the product with HEK cells grown in a SF media. We are eagerly awaiting the results.» Read More